Compare KRYS & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | KTOS |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 8.7B |
| IPO Year | 2017 | 1999 |
| Metric | KRYS | KTOS |
|---|---|---|
| Price | $365.80 | $48.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 18 |
| Target Price | ★ $297.60 | $96.71 |
| AVG Volume (30 Days) | 330.3K | ★ 4.4M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.00 | 18.18 |
| EPS | ★ 1.83 | 0.07 |
| Revenue | $389,130,000.00 | ★ $751,900,000.00 |
| Revenue This Year | $38.74 | $26.15 |
| Revenue Next Year | $32.53 | $23.43 |
| P/E Ratio | ★ $202.78 | $697.71 |
| Revenue Growth | ★ 33.94 | 12.44 |
| 52 Week Low | $130.50 | $46.01 |
| 52 Week High | $382.54 | $134.00 |
| Indicator | KRYS | KTOS |
|---|---|---|
| Relative Strength Index (RSI) | 60.23 | 39.18 |
| Support Level | $253.89 | $46.01 |
| Resistance Level | $382.54 | $78.77 |
| Average True Range (ATR) | 13.26 | 2.97 |
| MACD | -1.03 | 0.06 |
| Stochastic Oscillator | 55.77 | 16.36 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.